Literature DB >> 11866242

The surgical management of menorrhagia.

Jason A Abbott1, Ray Garry.   

Abstract

Surgical treatment of menorrhagia is likely to be both successful and satisfactory to the patient. Correct diagnosis of the cause of menorrhagia is essential, and management should be directed to the specific cause of the problem. The question of which treatment is best is a complex one and involves balancing patient wishes, expected outcomes, complications, cost-effectiveness and quality of life issues. For the subset of women in whom dysfunctional uterine bleeding is diagnosed, the literature suggests that there is a hierarchy of treatments that, in descending order for both efficacy and patient acceptability, are: (i) hysterectomy; (ii) endometrial ablation (either first- or second-generation); (iii) the levonorgestrel intrauterine system; and (iv) medical treatments. All four of these options should be discussed with the patient and the relative advantages and disadvantages considered before a treatment decision is made. For patients in whom a pathological cause is diagnosed, specific treatments should be aimed at removal of the lesion and observation of the effect on menstrual status. In addition to the treatment options above, specific treatments such as hysteroscopic, laparoscopic or open excision of the lesion need to be considered. For interventional radiological procedures such as uterine artery embolization, further study is recommended before it can be considered as a safe and effective treatment for menorrhagia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11866242     DOI: 10.1093/humupd/8.1.68

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  5 in total

1.  Computational analysis of endometrial photocoagulation with diffusing optical device.

Authors:  Jinhee Kwon; Chang-Yong Lee; Junghwan Oh; Hyun Wook Kang
Journal:  Biomed Opt Express       Date:  2013-10-14       Impact factor: 3.732

Review 2.  Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients.

Authors:  L J Middleton; R Champaneria; J P Daniels; S Bhattacharya; K G Cooper; N H Hilken; P O'Donovan; M Gannon; R Gray; K S Khan; J Abbott; J Barrington; S Bhattacharya; M Y Bongers; J-L Brun; R Busfield; M Sowter; T J Clark; J Cooper; K G Cooper; S L Corson; K Dickersin; N Dwyer; M Gannon; J Hawe; R Hurskainen; W R Meyer; H O'Connor; S Pinion; A M Sambrook; W H Tam; I A A van Zon-Rabelink; E Zupi
Journal:  BMJ       Date:  2010-08-16

3.  Decreased expression of c-kit and telomerase in a rat model of chronic endometrial ischemia.

Authors:  Jianguo Hu; Rui Yuan
Journal:  Med Sci Monit       Date:  2011-04

4.  A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia.

Authors:  Shirin Ghazizadeh; Fatemeh Bakhtiari; Haleh Rahmanpour; Fatemeh Davari-Tanha; Fatemeh Ramezanzadeh
Journal:  Int J Womens Health       Date:  2011-07-20

5.  Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial.

Authors:  Malou C Herman; Marian J van den Brink; Peggy M Geomini; Hannah S van Meurs; Judith A Huirne; Heleen P Eising; Anne Timmermans; Johanna M A Pijnenborg; Ellen R Klinkert; Sjors F Coppus; Theodoor E Nieboer; Ruby Catshoek; Lucet F van der Voet; Hugo W F van Eijndhoven; Giuseppe C M Graziosi; Sebastiaan Veersema; Paul J van Kesteren; Josje Langenveld; Nicol A C Smeets; Huib A A M van Vliet; Jan Willem van der Steeg; Yvonne Lisman-van Leeuwen; Janny H Dekker; Ben W Mol; Marjolein Y Berger; Marlies Y Bongers
Journal:  BMC Womens Health       Date:  2013-08-08       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.